Cargando…
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!
Breast cancer (BC), the most prevalent cancer in women, is a heterogenous disease. Despite advancements in BC diagnosis, prognosis, and therapeutics, survival rates have drastically decreased in the metastatic setting. Therefore, BC still remains a medical challenge. The evolution of high-throughput...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452617/ https://www.ncbi.nlm.nih.gov/pubmed/37626796 http://dx.doi.org/10.3390/biomedicines11082300 |